Biotech Week articles from May 2002

Biotech Week archives from May 2002

Troybodies study shows promising results.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Affitech has converted its option into an exclusive worldwide license for the novel vaccine delivery technology, Troybodies. The company made the decision after early investigations demonstrated the...

INGN 241 may work effectively as radiation sensitizer to make cancer cells vulnerable.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Introgen Therapeutics, Inc., (INGN) recently presented data from three preclinical studies showing that INGN 241, its mda-7 gene therapy product candidate, may work effectively as a radiation sensitizer...

Targacept extends collaboration for development of drugs to treat CNS diseases.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Targacept, Inc., announced the signing of a new collaborative research and license agreement with Aventis Pharma (AVE) to discover and develop drugs, derived from the Aventis Pharma library of...

Celsion files IND to initiate new therapy for treatment of prostate cancer.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Celsion Corp. (CLN) announced plans to undertake human clinical trials for a cancer therapy that, according to its chief investigator, has been successfully applied in small animal studies "with...

Major alliance focuses on discovery targets.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Genmab A/S and the privately owned Cambridge, U.K.-based Paradigm Therapeutics, Ltd., announced the formation of a broad-based collaboration to develop new antibody therapeutic products. The...

Companies agree to develop oral parathyroid hormone.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) and Unigene Laboratories, Inc., (UGNE) have completed a $150 million dollar licensing agreement to develop an oral formulation of an analog of parathyroid hormone (PTH) currently...

New patent awarded for Zicam secures, expands exclusive cold remedy formula.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Gum Tech International, Inc., (GUMM) announced that on April 2, 2002, the U.S. Patent Office issued a new patent for Zicam Cold Remedy, its unique product that has been shown to significantly reduce the...

Catalyst 4.7 is released.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Accelrys, Inc., announced the release of Catalyst 4.7, the company's lead identification and optimization application for speeding preclinical pharmaceutical research. Catalyst 4.7 now supports...

Company makes changes to management team.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Advancis Pharmaceutical Corp. announced that Kevin S. Sly has been appointed senior vice president, business development, and strategic marketing. Sly will report to Edward M. Rudnic, PhD, president and...

Company faces possible SEC action.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Akorn, Inc., (AKRN) announced that it has been informed that the staff of the Securities and Exchange Commission's regional office in Denver, Colorado, plans to recommend to the commission that it bring...

Company declares regular quarterly cash dividend.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., announced that its board of directors has declared a regular quarterly cash dividend of $0.045 per common share. The dividend was payable on April 26, 2002. It will be...

Company exchanges $70M convertible notes for class a common stock.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., a leading global specialty pharmaceutical company, announced that it has entered into agreements to issue approximately 4.4 million shares of the company's Class A Common Stock in...

Two key hires announced.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- As part of its recent expansion moves, life sciences informatics pioneer AnVil announced two senior hires to help direct its business and scientific operations. John J. Hallinan was named chief...

Aptus announces drug discovery collaboration.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Aptus Genomics, Inc., (Aptus) and Array BioPharma, Inc., (ARRY) announced a drug discovery collaboration agreement to create small molecule therapeutics against select G-protein coupled receptor (GPCR)...

Arimidex submitted for early breast cancer license extension in Europe.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- AstraZeneca announced that it has filed for a license extension of its aromatase inhibitor, Arimidex (anastrozole), for the treatment of postmenopausal women with early stage breast cancer via the...

Marius Sudol named to scientific advisory board.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- AxCell Biosciences, a subsidiary of Cytogen Corp. (CYTO), announced the appointment of Marius Sudol, PhD, to the company's scientific advisory board. Sudol is one of the world's foremost experts on the...

FDA okays generic Mircette; company to launch it under Kariva trademark.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) announced that the U.S. Food & Drug Administration (FDA) has granted final approval for its application to manufacture and market a generic version of Organon, Inc.'s,...

LyfjathrUun Biopharmaceuticals enters nasal drug delivery R&D partnership.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Bespak announced that it has successfully reached the next stage of its strategy for nasal drug delivery through the signing of a partnership agreement with LyfjathrUun Biopharmaceuticals, the leading...

Bio-Rad acquires Quantase.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO, BIO.B) announced the acquisition of Quantase, Ltd., of Perth, Scotland, a company specializing in newborn screening diagnostic products. Terms of the acquisition...

FDA advisory committee to review Amevive.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Biogen, Inc., (BGEN) announced that the U.S. Food and Drug Administration (FDA) will convene a Dermatologic and Opthalmic Drugs Advisory Committee on May 23, 2002 to review the registrational filing of...

John Palmer named senior vice president, corporate development.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Biogen, Inc., (BGEN) announced the appointment of John W. Palmer as senior vice president, corporate development. Palmer will supervise the company's global business development activities. He...

Pharmaceutical company uses Linux NetworX cluster to aid in drug discovery.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Linux NetworX announced that Boehringer Ingelheim Pharmaceuticals, Inc., is advancing its human healthcare research and development processes with a 120-processor Linux NetworX Evolocity cluster...

Initial long-term survival findings reported from head and neck cancer study of Multikine.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- CEL-SCI Corp. (CVM) announced that all eight head and neck cancer patients in a phase II clinical trial who were treated by one investigator in Hungary with CEL-SCI's immunotherapy drug, Multikine, in...

Aaron Heifetz named VP, general manager, and site director.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Dr. Aaron Heifetz has been appointed vice president, general manager, and site director of Cambrex Bio Science, Inc., a subsidiary of Cambrex Corp. (CBM). He will report to the chairman. Heifetz...

Company adds $2.5 million to credit facility.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Caraco Pharmaceutical Laboratories, Ltd., (CARA) has added $2.5 million to its unsecured credit facility at Bank of Nova Scotia, according to CEO Narendra N. Borkar. The total credit facility with...

Cell Based Delivery raises $9 million in private investment.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Cell Based Delivery, Inc., announced the completion of a $9 million private financing round, led by TVM Techno Venture Management and including ABN AMRO and The Vertical Group. Cell Based Delivery...

CellFactors launches of immortalized human neural cell lines.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- The launch of a library of immortalized human neural cell lines derived from the brain and spinal cord could transform the efficiency with which potential new drugs are discovered by the pharmaceutical...

Michael P. Miller named vice president, commercial operations.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., (CLGY) announced that Michael P. Miller has joined the company as vice president, commercial operations, assuming responsibility for Cellegy's marketing and sales efforts,...

Company announces phase II BPH results.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Celsion Corp. (CLN) announced results from the multisite phase II pivotal trial of its Microfocus BPH 800 Microwave Urethroplasty system used for the treatment of benign prostatic hyperplasia (BPH). ...

Cepheid granted two U.S. patents covering I-CORE DNA detection, sample preparation technology.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Cepheid (CPHD) announced the issuance of U.S. Patent No. 6,369,893 broadly covering the company's fundamental I-CORE module technology for simultaneous, real-time optical excitation and detection of two...

Advanced version of ACIS Tissue Microarray application launched.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- ChromaVision Medical Systems, Inc., (CVSN) announced the introduction of an advanced version of its ACIS Tissue Microarray application with improved automation and throughput, enhanced multitasking, and...

Gen-Probe files Form 10 with the SEC.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Chugai Pharmaceutical Co., Ltd., has announced that its wholly owned subsidiary, Gen-Probe, Inc., has filed Form 10 with the Securities and Exchange Commission. The filing is in connection with...

Transfac subscriptions renewed by Merck & Co. and Schering-Plough Research Institute.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Cognia Corp., developers and distributors of databases and knowledge tools for drug discovery, announced that Merck & Co., Inc., and Schering-Plough Research Institute have renewed their subscriptions...

Company strengthens management team, expands board of directors.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Coley Pharmaceutical Group announced the addition of John K. Whisnant, MD, as senior vice president, clinical and regulatory, and Charles E. Yon as vice president and general counsel. The company has...

Hungarian biotech wins prestigious innovation prize.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- ComGenex, Inc., of Budapest, Hungary, an integrated discovery chemistry provider, who this year celebrates its tenth anniversary of drug discovery support, is pleased to announce the winning of the top...

CompuCyte completes restructuring, financing round.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- CompuCyte Corp. announced that it has concluded a restructuring of its operations, allowing the company to refocus on its successful line of LSC Laser Scanning Cytometers. CompuCyte also reported the...

Samta K. Kundu named senior director of business development.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Consensus Pharmaceuticals, Inc., a privately held biopharmaceutical drug discovery company announced the appointment of Samta K. Kundu as senior director of business development. Prior to joining...

First quarter 2002 revenues increased 135%.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Dutch antibody and vaccine company Crucell (CRXL) saw its first quarter 2002 revenues increase by 135% compared with the same period last year. The pro forma loss increased by 60 %. The net loss...

First quarter 2002 financial results reported.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Curon Medical, Inc., (CURN) announced financial results for the first quarter ended March 31, 2002. For the first 3 months of 2002, Curon reported net sales of $940,000 compared with pro forma net...

Ephedrine-free Xenadrine-EFX launched.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Cytodyne Technologies, makers of the diet supplement, Xenadrine RFA-1, announced the introduction of an ephedrine-free formulation called Xenadrine-EFX. The new formula is based on the latest research...

Exchange offer by Cytyc extended.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Digene Corp. (DIGE) announced that Cytyc Corp. (CYTC) extended the expiration date of its offer to purchase for cash and stock all of the outstanding shares of common stock of Digene. This...

DeValerio Pease Tabacco Burt & Pucillo announces securities class action suit.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Investors claim Elan Corporation, PLC (ELN) used dozens of joint ventures to hide research and development costs and overstate the company's revenues, according to a pending lawsuit filed by Berman...

Amarin Corp. announces partial conversion of convertible preference shares by Elan.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Amarin Corp., plc, (AMRN) announced that Elan International Services, Ltd, has converted 2,129,819 shares of its Amarin convertible preference stock into 21,298,190 shares of Amarin ordinary stock...

Gen-Probe wins appeal in patent infringement case.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Gen-Probe, Inc., announced that the United States Court of Appeals for the Federal Circuit has affirmed a lower court decision dismissing a patent infringement lawsuit brought against it in 1999 by Enzo...

Fougera first to market generic Desonide lotion.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Fougera, a division of Altana, Inc., announces that it is the first company to receive FDA approval to market generic Desonide Lotion 0.05%. This product is AB-rated to DesOwen by Galderma, and is...

Health care advisory board established, members named.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Genencor International, Inc., (GCOR) announced the formation of a health care advisory board (HCAB) to assist with the company's pharmaceutical initiatives. The four-member board, comprising experts in...

Genmab announces first quarter financial results.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Genmab A/S announced results for the 3-month period ended March 31, 2002. During this period, Genmab reported a net loss of DKK 99.4 Mio., approximately USD 11.7 Mio., an operating loss of DKK 106.6...

Company files Form 10-SB with SEC.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- GenoMed, Inc., (GMED) a medical genomics biotechnology company, has voluntarily filed a Form 10-SB with the Securities and Exchange Commission pursuant to Section 12(g) of the Securities Exchange Act of...

Clotted blood suitable for genetic analysis.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Clotted blood samples can provide useful genetic information, according to researchers in the United States. Dr. Karissa K. Adkins and colleagues working...

BioWisdom announce a pilot project utilizing Discovery Insight.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- BioWisdom has announced a pilot project with GlaxoSmithKline, Stevenage, U.K. The pilot project will apply the BioWisdom technology in one of GlaxoSmithKline's key therapeutic areas. The aim of...

Company names scientific advisory board chairman.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- H-Quotient, Inc., (HQNT) announced that Thomas C. Laipply, MD, FCAP, FIAP, director of molecular tissue pathology, Nichols Institute at Quest Diagnostics, has been appointed chairman of the H-Quotient,...

Final prospectus filed for public offering.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Hemosol, Inc., (HMSL) announced that it has filed the final prospectus for its recently announced public offering of $22,050,000 units. The offering is expected to close on or about April 18, 2002....

Biopolymer Engineering successfully defends patents for (beta) 1,3 glucan nutritional supplements.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- The U.S. District Court, Minnesota District, has issued a permanent injunction prohibiting High Performance Living Corp. from selling nutritional supplements containing yeast (beta) 1,3 glucan in...

Human Genome Sciences announces first quarter 2002 financial results.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) announced financial results for the first quarter ended March 31, 2002. The company reported a net loss of $38.3 million, or $0.30 per share, for the quarter...

Tender offer is priced.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- ICN Pharmaceuticals, Inc., (ICN) announced, in connection with its previously announced tender offer and consent solicitation for all of the company's outstanding 8 3/4% Series B Senior Notes due 2008,...

Company announces agreement with Wyeth Consumer Healthcare.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Information Resources, Inc., (IRIC) announced that it has entered into an agreement with Wyeth Consumer Healthcare, a Madison, New Jersey based manufacturer and marketer of leading consumer healthcare...

BioAPI Specification approved as ANSI/INCITS 358.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- The BioAPI Consortium has announced that the BioAPI Specification, Version 1.1, has been approved and published as an American National Standard, designated as ANSI/INCITS 358. This approval is the...

Company reports 4Q, year-end 2001 financial results.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Keryx Biopharmaceuticals, Inc., (KERX; KRX), a drug discovery company focused on developing innovative therapies through its proprietary technologies for the treatment of critical medical conditions...

Joseph Santomauro appointed as vice president of business development, licensing.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals, Inc., (KOSP) announced that Joseph Santomauro has been appointed as vice president of business development and licensing (BD&L). Santomauro will be responsible for creating and...

Vincent DeVita appointed chairman of scientific advisory board.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Vincent T. DeVita, MD, former director of the National Cancer Institute, and has been appointed chairman of the scientific advisory board of Light Sciences Corp. "The depth and breadth of Dr....

Bullard named vice president, informatics, at Morphochem.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Brian R. Bullard has joined Morphochem, U.S., as vice president for informatics. Bullard had been vice president and chief information officer at AxCell Biosciences Corp. He will report to Eric M....

ICN's biotechnology unit goes public on NYSE.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- ICN Pharmaceuticals, Inc., said that it had "kept its promise" with the listing and sale of the IPO of its biotechnology unit Ribapharm on the New York Stock Exchange. The ticker symbol of the new...

Joerg Spiekerkoetter to join executive board.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- The Supervisory Board of Schering AG has appointed a new member to its board of executive directors. Joerg Spiekerkoetter began his tenure as a deputy member of the board on April 15, 2002. Joerg...

David Ebsworth to join board of directors.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- SkyePharma PLC (SKYE) announced the appointment of a new nonexecutive director, David Ebsworth, PhD, formerly worldwide head of the pharmaceutical division of Bayer AG (BAY). The appointment takes...

Connetics grants license to Novartis For Liquipatch technology in antifungal use.
May 8, 2002... 2002 MAY 8 - (NewsRx.com & NewsRx.net) -- Connetics Corp. (CNCT), a specialty pharmaceutical company focused exclusively on the development and commercialization of dermatology products, announced that its wholly owned subsidiary, Soltec...

Researchers identify key gene that regulates immune response.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Researchers at Princess Margaret Hospital's Ontario Cancer Institute (OCI) and Amgen Research Institute have discovered that controlling a specific gene could prevent the body's immune system from...

Visilizumab may be useful for graft-versus-host treatment.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A novel drug may help physicians treat severe complications after stem cell transplantation, researchers in the United States report. "Visilizumab is a...

Collaboration to focus on development of diagnostic tests for BSE, CJD.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories and the University of Zurich, Switzerland, announced that they have entered into a licensing agreement and a research collaboration for the development of in vitro diagnostic tests...

Companies sign $44M agreement for novel vaginal drug delivery technology.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) announced that it has signed an agreement for the acquisition of certain assets and liabilities of Enhance Pharmaceuticals, Inc., of Princeton, New Jersey, for $44...

Preliminary results show TAXUS III paclitaxel-eluting stent is safe.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corp. (BSX) announced preliminary, 6-month results of its TAXUS III paclitaxel-eluting stent clinical trial. TAXUS III is a single-arm registry examining the feasibility of...

Agreement with Duke University Medical Center to focus on microarray technology.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Expression Analysis (EA), a new Durham-based biotechnology company that uses a sophisticated gene analysis technology to support genomics research, has entered into a collaborative services agreement...

Minimally invasive surgical procedure for arthritis may delay knee replacement surgery.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- A promising new treatment for people suffering from early stage osteoarthritis of the knee is now available in the United States. The UniSpacer Knee System, manufactured by Sulzer Orthopedics, Inc., a...

FDA committee declines to approve Picovir.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- ViroPharma, Inc., (VPHM) and Aventis Pharmaceuticals (AVE) have announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to not recommend Picovir...

Eric Meyers promoted to chief operating officer.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- 3rd Millennium, a leading bioinformatics consulting firm, announced that Eric Meyers, previously serving as vice president of marketing and business development, has been promoted to chief operating...

Company reports fiscal 2001 financial results.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- AMDL, Inc., (ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, reported fiscal 2001 financial results. Revenues for the year ended December 31,...

Seed financing completed.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- ARC Pharmaceuticals, Inc., has successfully completed a private offering of common shares with gross proceeds of $550,000. Investors include company founders, employees, and a group of private...

New chief financial officer named.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced the appointment of Michael S. Durski as vice president finance and administration and chief financial officer. Durski brings more than 25 years of financial...

Company announces resignation of chairman.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc., (ABRX, ABRX) announced C. Robert Cusick has resigned as chairman of the board and as a director of the company so he may focus solely on the continued development and growth of...

Consent decree over failure to comply with FDA manufacturing practices dissolved.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc., (ABRX, ABRX) announced that the consent decree the company was subject to and entered by the United States District Court (District of New Jersey) on April 8, 1992 has been...

Company launches Zindaclin in the United Kingdom.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc., (AKC) announced that Strakan, Ltd., the worldwide licensee of its ResiDerm technology, has launched Zindaclin on the United Kingdom market. Also, the process to achieve...

Australian biotech enters into GPCR collaboration.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Alchemia Pty, Ltd., an Australian chemistry and drug discovery company, and Euroscreen SA, a Belgian biotechnology company specialized in G protein-coupled receptor (GPCR) research, announced that they...

Companies announce supplemental agreement for PulmoSpheres technology.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Alliance Pharmaceutical Corp. (ALLP) and Inhale Therapeutic Systems, Inc., (INHL) have expanded their agreement regarding the PulmoSpheres particle and particle processing technology, aspects of which...

Companies will focus on patient-friendly depot drug delivery systems.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Antares Pharma (ANTR) based in Exton, Pennsylvania, and MacroMed, Inc., a private company based in Salt Lake City, Utah, announced a technology and business development collaboration. In this...

Michael A. Nemzek named as executive VP of business development.
May 15, 2002... 2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Aspira Biosystems, Inc., announced that Michael A. Nemzek has been named executive vice president of business development. Nemzek will be responsible for leading the company's commercial efforts...